Pathomorphological variants of midventricular obstruction of interventricular septum during hypertrophic

V D Rozenberg1, L M Nepomnyashchikh

  • 1Department of General Pathology and Pathomorphology, Institute of Regional Pathology and Pathomorphology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia.

Insights

Hypertrophic cardiomyopathy involves diverse interventricular septum thickening patterns, impacting cardiac hemodynamics. These geometric changes explain discrepancies between echocardiographic and pathomorphological findings in hypertrophic cardiomyopathy.

Area of Science:

  • Cardiology
  • Pathology
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) is a significant cause of cardiac morbidity and mortality.
  • Understanding the diverse structural changes in HCM is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To investigate the specific variants and forms of interventricular septum hypertrophy in patients with hypertrophic cardiomyopathy.
  • To correlate geometrical structural changes with intracardiac hemodynamics and diagnostic data.

Main Methods:

  • Postmortem cardiac ventriculography, coronarography, and cardiometry were utilized.
  • Echocardiography and pathomorphological data correlation techniques were employed.
  • Examination of 100 hearts from patients deceased from hypertrophic cardiomyopathy.

Main Results:

  • Identified distinct variants of midventricular hypertrophy, including midleft ventricular, midright ventricular, midproximal, and midmaximal obstruction.
  • Documented isolated distal apex and apical hypertrophy.
  • Observed multiplanar variability and mobility of the interventricular septum with a catenary shape.

Conclusions:

  • Specific geometric alterations in the septum and left ventricle define various hypertrophic cardiomyopathy phenotypes.
  • Interventricular septum characteristics contribute to abnormal intracardiac hemodynamics.
  • These factors explain diagnostic discrepancies and are key to understanding hypertrophic cardiomyopathy pathogenesis and outcomes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...